The Financial Express
 
 
 
 

 

 
   CORPORATE
Monday, January 07, 2002 

Price control on natural Vitamin E to help E Merck

Kailash Rajwadkar

Mumbai, Jan 6: E Merck India is expecting to reap the benefits in turnover from its ‘synthetic’ vitamin E, following the National Pharmaceutical Pricing Authority’s (NPPA) decision to bring the ‘natural’ vitamin E formulation under price control. NPPA’s decision to levy a ceiling on the formulation comes even as its bulk drug continues to be outside the purview of price control.

As a result of the NPPA decision, producers of natural vitamin E are likely to find it unfeasible to produce and market natural vitamin E formulations as its processing is two to three times more expensive when compared with the processing of synthetic vitamin E, coupled with lower yields, E Merck India, director, RL Shenoy, said.

Though no concrete data is available, industry sources indicated that natural vitamin E would constitute around 20 per cent of the total demand.

Subsequent to the price revision, prices of natural vitamin E capsules now work out to Rs 7.38 for a strip of 10 capsules, as against E Merck India’s Rs 6.44 for 10 capsules. Currently, the company derives a turnover of around Rs 30 crore per annum from synthetic vitamin E formulation and also enjoys satisfactory margins, Mr Shenoy said.

However, analysts state that though the company is the sole manufacturer in the country, it faces stiff competition from cheaper Chinese imports. The consumption of vitamin E in India is also less when compared with China and other developed countries, analysts said.

E Merck India — the only producer of the synthetic vitamin E both bulk and formulation in the country — has a capacity to produce 350 tonnes of synthetic vitamin E which is used for captive consumption for producing formulations. Its Evion brand (vitamin E) accounts for a 40-per cent market share, according to the analysts.

Meanwhile, the royalty payment from E Merck India to its parent would work out to around Rs 2.5 crore per annum.

This was after the company received an approval from the Foreign Investment Promotion Board (FIPB) for royalty payment to its parent.

 

 
Write to the Editor
Mail this story
Print this story
 
 
 
   
 
About Us | Advertise With Us | Privacy Policy | Feedback
© 2002: Indian Express Newspapers (Bombay) Ltd. All rights reserved throughout the world.